Lv2
174 积分 2022-06-28 加入
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
22小时前
待确认
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
22小时前
已完结
Correspondence - Tranexamic acid for traumatic brain injury
22小时前
已完结
What dose of external-beam radiation is high enough for prostate cancer?
2天前
已完结
Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate
8天前
已完结
Resistance to second-generation androgen receptor antagonists in prostate cancer
8天前
已完结
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?
10天前
已完结
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
23天前
已完结
PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer
1个月前
已完结
Letter to the Editor: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone sensitive prostate cancer: CAPItello-281 phase III study
1个月前
已完结
皖公网安备34019202002308
